Management of neurogenic orthostatic hypotension

Journal of the American Medical Directors Association

Volumn 15, Issue 4, 2014, Pages 234-239

  Arbique, Debbie ^a   Cheek, Dennis ^b   Welliver, Mark ^b   Vongpatanasin, Wanpen ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b TEXAS CHRISTIAN UNIVERSITY   (United States)

Author keywords

Diagnostic tests; Morbidity; Mortality; Neurogenic; Neurogenic orthostatic hypotension; Pharmacological and nonpharmacological; Physiology and pathophysiology with standing; Supine hypertension

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; FLUDROCORTISONE; HYPERTENSIVE AGENT; LOOP DIURETIC AGENT; MIDODRINE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; PYRIDOSTIGMINE; THIAZIDE DIURETIC AGENT; VASODILATOR AGENT; VASOCONSTRICTOR AGENT;

AGE DISTRIBUTION; BLOOD PRESSURE MONITORING; BLOOD VOLUME; COLD PRESSOR TEST; ELECTROCARDIOGRAPHY; HUMAN; MEDICAL HISTORY; MEDICAL LITERATURE; MORBIDITY; MORTALITY; MUSCLE ISOMETRIC CONTRACTION; NEUROGENIC ORTHOSTATIC HYPOTENSION; NEUROLOGIC DISEASE; ORTHOSTATIC HYPOTENSION; PATIENT EDUCATION; PRESSORECEPTOR; PREVALENCE; REVIEW; SLEEP; STANDING; STUDY; SUPINE POSITION; VASODILATATION; ADULT; FEMALE; HEAT; HYPOTENSION, ORTHOSTATIC; MALE; PATHOPHYSIOLOGY;

ADULT; FEMALE; HOT TEMPERATURE; HUMANS; HYPOTENSION, ORTHOSTATIC; MALE; VASOCONSTRICTOR AGENTS;

EID: 84897029012     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2013.10.014     Document Type: Review

References (50)

1. Figueroa J.J., Basford J.R., Low P.A. Preventing and treating orthostatic hypotension: As easy as A, B, C. Cleveland Clin J Med 2010, 77:298-306.
2. Verwoert G.C., Mattace-Raso F.U.S., Hofman A., et al. Orthostatic hypotension and risk of cardiovascular disease in elderly people: The Rotterdam study. JAm Geriatr Soc 2008, 56:1816-1820.
3. Medow M.S., Stewart J.M., Sanyal S., et al. Pathophysiology, diagnosis, and treatment of orthostatic hypotension and vasovagal syncope. Cardiol Rev 2008, 16:4-20.
4. Low P.A. Benarroch EE Clinical Autonomic Disorders 2008, Lippincott Williams & Wilkins, Philadelphia, PA. 3rd ed.
5. Low P.A., Singer W. Management of neurogenic orthostatic hypotension: An update. Lancet Neurol 2008, 7:451-458.
6. Pickering T.G., Hall J.E., Appel L.J., et al. Recommendations for blood pressure measurement in humans: An AHA scientific statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee. JClin Hypertens (Greenwich, Conn) 2005, 7:102-109.
7. Vinik A.I., Maser R.E., Mitchell B.D., Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003, 26:1553-1579.
8. Cleophas T.J., van Marum R. Age-related decline in autonomic control of blood pressure: Implications for the pharmacological management of hypertension in the elderly. Drugs Aging 2003, 20:313-319.
9. Robertson D. The pathophysiology and diagnosis of orthostatic hypotension. Clin Autonomic Res 2008, 18:2-7.
10. Goldstein D.S., Robertson D., Esler M., et al. Dysautonomias: Clinical disorders of the autonomic nervous system. Ann Int Med 2002, 137:753-763.
11. Chen L.Y., Benditt D.G., Shen W. Management of syncope in adults: An update. Mayo Clin Proc 2008, 83:1280-1293.
12. Hermosillo A.G., Márquez M.F., Jáuregui-Renaud K., Cárdenas M. Orthostatic hypotension. Cardiol Rev 2001, 9:339-347.
13. Vongpatanasin W., Victor R.G. Orthostatic Disorders in hypertension. Hypertension: Principles and Practice, 1st ed 2005, 601-611. Informa Healthcare, New York. E. Battegay, G.L. Bakris, G.Y. Lip (Eds.).
14. Mathias C.J. Autonomic diseases: Clinical features and laboratory evaluation. JNeurol Neurosurg Psychiatry 2003, 74:iii31-41.
15. Naschitz J.E., Rosner I. Orthostatic hypotension: Framework of the syndrome. Postgraduate Med J 2007, 83:568-574.
16. Oldenburg O., Mitchell A., Nürnberger J., et al. Ambulatory norepinephrine treatment of severe autonomic orthostatic hypotension. JAm Coll Cardiol 2001, 37:219-223.
17. Sartori M., Pessina A.C. [Orthostatic hypotension and supine hypertension in pure autonomic failure]. Ital Heart J Suppl 2004, 5:879-883.
18. Rutan G.H., Hermanson B., Bild D.E., et al. Orthostatic hypotension in older adults. The Cardiovascular Health Study. CHS Collaborative Research Group. Hypertension 1992, 19:508-519.
19. Department of Health & Human Services: Administration on Aging. (2010, January 12). Aging Statistics. Available at. Accessed on February 21,2010. http://www.aoa.gov/aoaroot/aging_statistics/index.aspx.
20. Eigenbrodt M.L., Rose K.M., Couper D.J., et al. Orthostatic hypotension as a risk factor for stroke: the atherosclerosis risk in communities (ARIC) study, 1987-1996. Stroke 2000, 31:2307-2313.
21. Ko S.H., Song K.H., Park S.A., et al. Cardiovascular autonomic dysfunction predicts acute ischaemic stroke in patients with type 2 diabetes mellitus: A 7-year follow-up study. Diabetic Med 2008, 25:1171-1177.
22. Fedorowski A., Hedblad B., Melander O. Early postural blood pressure response and cause-specific mortality among middle age adults. Eur J Epidemiol 2011, 27:537-546.
23. Rose K.M., Eigenbrodt M.L., Biga R.L., et al. Orthostatic hypotension predicts mortality in middle-aged adults: The Atherosclerosis Risk In Communities (ARIC) Study. Circulation 2006, 114:630-636.
24. Ejaz A.A., Haley W.E., Wasiluk A., et al. Characteristics of 100 consecutive patients presenting with orthostatic hypotension. Mayo Clin Proc 2004, 79:890-894.
25. Lipsitz L.A., Ryan S.M., Parker J.A., et al. Hemodynamic and autonomic nervous system responses to mixed meal ingestion in healthy young and old subjects and dysautonomic patients with postprandial hypotension. Circulation 1993, 87:391-400.
26. Shannon J.R., Diedrich A., Biaggioni I., et al. Water drinking as a treatment for orthostatic syndromes. Am J Med 2002, 112:355-360.
27. Jordan J. New trends in the treatment of orthostatic hypotension. Current Hypertens Reports 2001, 3:216-226.
28. Shepherd J.T., Vanhoutte P.M. Role of the venous system in circulatory control. Mayo Clin Proc 1978, 53:247-255.
29. Shibao S., Lipsitz L.A., Biaggioni I. ASH position paper: Evaluation and treatment of orthostatic hypotension. JClin Hypertens 2013, 15:147-153.
30. Timmers H.J.L.M., Karemaker J.M., Wieling W., et al. Baroreflex control of muscle sympathetic nerve activity after carotid body tumor resection. Hypertension 2003, 42:143-149.
31. Goldstein D.S. Dysautonomia in Parkinson's disease: Neurocardiological abnormalities. Lancet Neurol 2003, 669-676.
32. Eisenhofer G., Friberg P., Goldstein D.S., Esler M. Differential actions of desipramine on sympathoadrenal release of noradrenaline and adrenaline. Br J Clin Pharmacol 1995, 40:263-265.
33. Fotherby M.D., Robinson T.D., Potter J.F. Clinic and 24-hour blood pressure in elderly treated hypertensives with postural hypotension. JHum Hypertens 1994, 8:711-716.
34. Jordan J., Shannon J.R., Pohar B., et al. Contrasting effects of vasodilators on blood pressure and sodium balance in the hypertension of autonomic failure. JAm Soc Nephrol 1999, 10:35-42.
35. Low P.A., Vernino S., Suarez G. Autonomic dysfunction in peripheral nerve disease. Muscle Nerve 2003, 27:646-661.
36. Masuo K., Mikami H., Ogihara T., et al. Changes in frequency of orthostatic hypotension in elderly hypertensive patients under medications. Am J Hypertens 1996, 9:263-268.
37. Poon I.O., Braun U. High prevelence of orthostatic hypotension and its correlation with potentially causative medications among elderly veterans. JClin Pharmacol Ther 2005, 30:173-178.
38. Dewey R., Holmburg V. Ergotamine/caffeine treatment of orthostatic hypotension in parkinsonism with autonomic failure. Eur J Neurol 1998, 5:593-599.
39. Jankovic J., Gilden J.L., Hiner B.C., et al. Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine. Am J Med 1993, 95:38-48.
40. Schrage W.G., Eisenach J.H., Dinenno F.A., et al. Effects of midodrine on exercise-induced hypotension and blood pressure recovery in autonomic failure. JAppl Physiol (Bethesda, MD 1985) 2004, 97:1978-1984.
41. Singer W., Sandroni P., Opfer-Gehrking T.L., et al. Pyridostigmine treatment trial in neurogenic orthostatic hypotension. Arch Neurol 2006, 63:513-518.
42. Ward C.R., Gray J.C., Gilroy J.J., Kenny R.A. Midodrine: A role in the management of neurocardiogenic syncope. Heart (British Cardiac Society) 1998, 79:45-49.
43. Maule S., Papotti G., Naso D., et al. Orthostatic hypotension: Evaluation and treatment. Cardiovasc Hematol Disord Drug Targets 2007, 7:63-70.
44. Shibao C., Gamboa A., Abraham R., et al. Clonidine for the treatment of supine hypertension and pressure natriuresis in autonomic failure. Hypertension 2006, 47:522-526.
45. Jansen R.W., Lipsitz L.A. Postprandial hypotension: epidemiology, pathophysiology, and clinical management. Ann Intern Med 1995, 122:286-295.
46. Jordan J., Shannon J.R., Grogran E., et al. Apotent pressor response eliciated by drinking water. Lancet 1999, 353:723.
47. Schroeder C., Bush V.E., Norcliffe L.J., et al. Water drinking acutely improves orthostatic tolerance in healthy subjects. Circulation 2002, 106:2806-2811.
48. Ten Harkel A.D., Van Lieshout J.J., Wieling W. Treatment of orthostatic hypotension with sleeping in the head-up tilt position, alone and in combination with fludrocortisone. JIntern Med 1992, 232:139-145.
49. Ector H., Reybrouch T., Heidbuchel H., et al. Tilt training: A new treatment for recurrent neurocardiogenic syncope and severe orthostatic intolerance. Pacing Clin Electophysiol 1998, 21:193-196.
50. Ten Harkel A.D., Van Lieshout J.J., Wieling W. Effects of leg muscle pumping and tensing on orhtostatic arterial pressure: A study in normal sujects and patients with autonomic failure. Clin Sci London 1994, 87:553-558.